Just on Pfizer's involvement: Eight of the authors of this paper work at New Opportunities Unit, Pfizer Global Research and Development, Sandwich, UK (Pfizer did not close all its operations at Sandwich); one of the authors works for Neusentis, Pfizer Global Research & Development, Cambridge, UK and two work for Analytical Sciences, Pfizer Global Research and Development, Sandwich, UK.
So Pfizer pay for eleven scientist to work on this research and we pay for just one, Dr Suhy. This looks like more than just a passing interest to me. Who is the driving force here, us or them? Or did we pay Pfizer to participate and this came out of our R&D? Either way Pfizer putting their name to this research can only be a good thing for BLT.
- Forums
- ASX - By Stock
- BLT
- pfizer back in town - tacere last paper
pfizer back in town - tacere last paper, page-4
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)